Heterozygous germline TET2 loss-of-function variants associated with an ALPS-like phenotype

IF 3.8 2区 医学 Q1 HEMATOLOGY British Journal of Haematology Pub Date : 2025-03-03 DOI:10.1111/bjh.20042
Sean Harrop, Joshua Casan, Hannah Rose, Michael Sullivan, Sam Mehr, Henry Ngu, Imogen Caldwell, Joseph McKendrick, Mary Ann Anderson, Nicole Den Elzen, Erin Goode, Lucy C. Fox, Stephen Lade, Piers Blombery
{"title":"Heterozygous germline TET2 loss-of-function variants associated with an ALPS-like phenotype","authors":"Sean Harrop,&nbsp;Joshua Casan,&nbsp;Hannah Rose,&nbsp;Michael Sullivan,&nbsp;Sam Mehr,&nbsp;Henry Ngu,&nbsp;Imogen Caldwell,&nbsp;Joseph McKendrick,&nbsp;Mary Ann Anderson,&nbsp;Nicole Den Elzen,&nbsp;Erin Goode,&nbsp;Lucy C. Fox,&nbsp;Stephen Lade,&nbsp;Piers Blombery","doi":"10.1111/bjh.20042","DOIUrl":null,"url":null,"abstract":"<p>Germline homozygous loss-of-function mutations in <i>TET2</i> result in significant childhood immunodeficiency that resembles autoimmune lymphoproliferative syndrome and predisposes one to lymphoma. The implications of heterozygous variants are less well understood. We describe four patients with heterozygous germline loss-of-function <i>TET2</i> mutations who presented with B-cell lymphoma on a background of chronic lymphadenopathy and autoimmune features. This expands the association of germline <i>TET2</i> mutations with lymphoma and an autoimmune lymphoproliferative syndrome-like phenotype to the heterozygous state. Assessment for <i>TET2</i> mutations and germline origin should be considered in the appropriate context, as recognition of these variants may have implications on patient care.</p>","PeriodicalId":135,"journal":{"name":"British Journal of Haematology","volume":"206 5","pages":"1330-1334"},"PeriodicalIF":3.8000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bjh.20042","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Haematology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bjh.20042","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Germline homozygous loss-of-function mutations in TET2 result in significant childhood immunodeficiency that resembles autoimmune lymphoproliferative syndrome and predisposes one to lymphoma. The implications of heterozygous variants are less well understood. We describe four patients with heterozygous germline loss-of-function TET2 mutations who presented with B-cell lymphoma on a background of chronic lymphadenopathy and autoimmune features. This expands the association of germline TET2 mutations with lymphoma and an autoimmune lymphoproliferative syndrome-like phenotype to the heterozygous state. Assessment for TET2 mutations and germline origin should be considered in the appropriate context, as recognition of these variants may have implications on patient care.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
杂合子种系TET2功能丧失变异与alps样表型相关。
TET2的种系同源功能缺失突变会导致严重的儿童免疫缺陷,类似于自身免疫性淋巴细胞增生综合征,并容易导致淋巴瘤。人们对杂合变异的影响了解较少。我们描述了四名患有杂合子种系功能缺失 TET2 突变的患者,他们在慢性淋巴结病和自身免疫特征的背景下出现了 B 细胞淋巴瘤。这将种系TET2突变与淋巴瘤和自身免疫性淋巴组织增生综合征类似表型的关系扩大到了杂合子状态。对TET2突变和种系起源的评估应在适当的背景下进行,因为识别这些变异可能会对患者护理产生影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
8.60
自引率
4.60%
发文量
565
审稿时长
1 months
期刊介绍: The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.
期刊最新文献
Microplastic contamination of donated blood and red cell concentrates. Microvascular and microstructural brain abnormalities in paediatric haematological cancer survivors are related to cognitive deficits: An IVIM-FWI MRI study. Dose de-escalation of alemtuzumab in matched unrelated donor haematopoietic stem cell transplantation. Deregulated megakaryocytic maturation, mitochondrial function and inflammatory signalling in CYCS(c.292T>C)-related thrombocytopenia. Equal outcomes after human leukocyte antigen-matched unrelated versus sibling donor transplants-Results of the AML SCT-BFM 2007 trial and consecutive 'real-world routine'.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1